Back to team page

Larry Becker

Director

Larry has more than 20 years’ experience creating, analyzing, and optimizing online user experiences. During his career Larry has led e-commerce for a leading national retailer, introduced website optimization services at an Inc 500 advertising agency, and led digital marketing for a top-ranked global business school. Larry’s passion is helping organizations find the sweet spot where user needs and business needs intersect. He enjoys learning new frameworks, breaking new ground, and working collaboratively to organize chaos without stifling creativity. Larry holds a BA from the University of Virginia.

Bold facts

Learn more about

Larry

Something unique about you summed up in one sentence:

I have an exceptionally high tolerance for ambiguity.

Your favorite part of working at Bold Insight

Working with incredibly smart and kind people who are genuinely dedicated to helping clients and each other realize their potential.

In your spare time (or if you had spare time), you would absolutely do this:

Take long walks in exotic places.

Your favorite city in the world is...and why?

San Francisco and New York, both for food, culture and vibe. They are indeed quite different, but as noted, I’m more than OK with ambiguity.

You cannot start the day without doing this:

Breathing deeply. And drinking coffee.

Your ultimate celebrity dinner party guest list would include:

Little Richard, Willie Nelson, Francois Truffaut, and Joan Didion. Would that gel? I don’t know, but I figure Richard would keep things lively.

Long-term personal or professional goal?

To continue to learn and develop as a musician. It brings me joy and teaches me ways to learn about just about everything else.

Any other facts to share?

I once performed the song “Wild Thing” during a religious service. It was well-received.
Read Larry's bold insights

Read our team’s latest bold insights

Human factors testing for OTC drugs and non-prescription medical devices

Jan 16, 2025

As the field of human factors continues to evolve, so must our approaches to testing and study design. While the FDA’s 2013 guidance laid the groundwork for study design and methodology, recent discussions and conference presentations have prompted a shift in how we approach OTC HF testing, leading to more comprehensive and realistic assessments of these products.

read more